Lonza Group Ag Gross Profit 2012-2024 | LZAGY

Lonza Group Ag annual/quarterly gross profit history and growth rate from 2012 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Lonza Group Ag gross profit for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Lonza Group Ag gross profit for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Lonza Group Ag annual gross profit for 2024 was $2.454B, a 13.07% increase from 2023.
  • Lonza Group Ag annual gross profit for 2023 was $2.17B, a 15.07% decline from 2022.
  • Lonza Group Ag annual gross profit for 2022 was $2.555B, a 10.67% increase from 2021.
Lonza Group Ag Annual Gross Profit
(Millions of US $)
2024 $2,454
2023 $2,170
2022 $2,555
2021 $2,309
2020 $1,971
2019 $2,270
2017 $1,858
2016 $1,422
2015 $1,144
2014 $1,175
2013 $892
2012 $1,072
2011 $793
Lonza Group Ag Quarterly Gross Profit
(Millions of US $)
2024-12-31
2024-06-30
2023-12-31
2023-06-30
2022-12-31
2022-06-30
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2019-06-30
2018-12-31
2018-06-30
2017-12-31
2017-06-30
2016-12-31
2016-06-30
2015-12-31
2015-06-30
2014-12-31
2014-06-30
2013-12-31
2013-06-30
2012-12-31
2012-06-30
2011-12-31
2011-06-30
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $49.265B $7.468B
Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $230.372B 27.70
Boston Scientific (BSX) United States $149.971B 37.54
Stryker (SYK) United States $142.469B 29.79
EssilorLuxottica (ESLOY) France $128.310B 0.00
Medtronic (MDT) Ireland $109.952B 15.59
Haleon (HLN) United Kingdom $47.015B 26.80
ResMed (RMD) United States $36.786B 27.63
GE HealthCare Technologies (GEHC) United States $32.917B 15.63
Agilent Technologies (A) United States $32.815B 21.39
Terumo (TRUMY) Japan $26.606B 34.56
Koninklijke Philips (PHG) Netherlands $21.242B 14.90
Insulet (PODD) United States $21.238B 83.37
Zimmer Biomet Holdings (ZBH) United States $17.915B 11.51
Baxter (BAX) United States $15.293B 11.42
Smith & Nephew SNATS (SNN) United Kingdom $12.517B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $9.087B 0.00
Bio-Rad Laboratories (BIO) United States $6.313B 21.97
Lantheus Holdings (LNTH) United States $5.465B 13.78
Prestige Consumer Healthcare (PBH) United States $4.133B 18.46
Perrigo (PRGO) Ireland $3.618B 9.17
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.366B 15.33
ICU Medical (ICUI) United States $3.165B 23.34
Envista Holdings (NVST) United States $3.154B 26.21
GN Store Nord (GNNDY) Denmark $2.272B 18.82
QuidelOrtho (QDEL) United States $1.916B 13.18
LeMaitre Vascular (LMAT) United States $1.846B 41.26
AtriCure (ATRC) United States $1.565B 0.00
Acuren (TIC) United States $1.335B 0.00
AdaptHealth (AHCO) United States $1.144B 11.62
Neogen (NEOG) United States $1.083B 13.86
Green Thumb Industries (GTBIF) United States $1.059B 23.81
BioLife Solutions (BLFS) United States $1.022B 0.00
Phibro Animal Health (PAHC) United States $0.971B 12.41
InMode (INMD) Israel $0.843B 8.50
Kestra Medical Technologies (KMTS) United States $0.796B 0.00
CeriBell (CBLL) United States $0.643B 0.00
Evolus (EOLS) United States $0.600B 0.00
Owens & Minor (OMI) United States $0.576B 4.78
Curaleaf Holdings (CURLF) Canada $0.547B 0.00
Capricor Therapeutics (CAPR) United States $0.545B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.512B 0.00
Valneva SE (VALN) France $0.487B 0.00
Surmodics (SRDX) United States $0.417B 0.00
Tilray Brands (TLRY) Canada $0.386B 0.00
SNDL (SNDL) Canada $0.334B 0.00
VAREX IMAGING (VREX) United States $0.316B 11.62
SEMPERIT AG HLD (SEIGY) Austria $0.307B 0.00
Sanuwave Health (SNWV) United States $0.282B 0.00
Aurora Cannabis (ACB) Canada $0.263B 78.00
Viemed Healthcare (VMD) United States $0.260B 21.93
Cerus (CERS) United States $0.256B 0.00
Quanterix (QTRX) United States $0.248B 0.00
Sanara MedTech (SMTI) United States $0.245B 0.00
ZimVie (ZIMV) United States $0.240B 10.90
Canopy Growth (CGC) Canada $0.237B 0.00
Cresco Labs (CRLBF) United States $0.236B 0.00
Biote (BTMD) United States $0.218B 6.14
OraSure Technologies (OSUR) United States $0.215B 0.00
Brainsway (BWAY) Israel $0.208B 55.15
TriSalus Life Sciences (TLSI) United States $0.204B 0.00
Verano Holdings (VRNOF) United States $0.192B 0.00
Omeros (OMER) United States $0.189B 0.00
High Tide (HITI) Canada $0.178B 0.00
Organigram Global (OGI) Canada $0.177B 0.00
Utah Medical Products (UTMD) United States $0.174B 14.20
Exagen (XGN) United States $0.157B 0.00
Vireo Growth (VREOF) United States $0.133B 0.00
FitLife Brands (FTLF) United States $0.128B 15.76
Jin Medical (ZJYL) China $0.110B 0.00
Veru (VERU) United States $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Fonar (FONR) United States $0.087B 11.25
MacroGenics (MGNX) United States $0.086B 0.00
Quipt Home Medical (QIPT) United States $0.078B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
Agape ATP (ATPC) $0.076B 0.00
Zynex (ZYXI) United States $0.073B 0.00
Cytosorbents (CTSO) United States $0.073B 0.00
InterCure (INCR) Israel $0.068B 0.00
Apyx Medical (APYX) United States $0.065B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.055B 0.00
Modular Medical (MODD) United States $0.044B 0.00
Nephros (NEPH) United States $0.038B 51.14
United-Guardian (UG) United States $0.038B 12.98
Rockwell Medical (RMTI) United States $0.032B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
Cellectar Biosciences (CLRB) United States $0.017B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
INLIF (INLF) $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
Senestech (SNES) United States $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.007B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00